Prelude Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,900
Closed -$423K 1554
2020
Q4
$423K Buy
7,900
+3,400
+76% +$176K 0.01% 778
2020
Q3
$211K Buy
+4,500
New +$231K 0.01% 669

Other funds holding CAH

Prelude Capital Management's CAH Position: Q2 2025 in Review

Prelude Capital Management sold out of Cardinal Health (CAH) in Q2 2025, closing a stake of 3,199 shares — an estimated $441K sold.

Prelude Capital Management first reported a position in CAH in Q3 2013 and held it in 36 quarters. The position peaked at $1.32M in Q3 2022. 1,254 funds tracked by Wall St. Rank hold CAH as of Q2 2025.

  • Prelude Capital Management reported no remaining Cardinal Health position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 3,199 Cardinal Health shares in Q2 2025, an estimated $441K.
  • Prelude Capital Management first reported a position in Cardinal Health in Q3 2013 and held it in 36 quarters.
  • Prelude Capital Management's Cardinal Health position peaked at $1.32M in Q3 2022.
  • 1,254 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.